Arrakis Therapeutics completes venture financing

On Feb. 27, RNA company Arrakis Therapeutics Inc. (Waltham, Mass.) raised an undisclosed amount in a tranched $38 million series A round led by Canaan Partners. New investors Pfizer Inc., Celgene Corp...